Prosthesis-patient mismatch (PPM) is defined as a too-small effective orifice area (EOA) of an inserted prosthetic relative to body size, resulting in an abnormally high postoperative gradient. It is unclear, however, whether residual stenosis after aortic valve replacement (AVR) has a negative impact on mid-and long-term survivals. We searched electronic databases, including PubMed, Embase, Medline and the Cochrane controlled trials register, through October 2012, to identify published full-text English studies on the association between PPM and mortality rates. A significant PPM was defined as an indexed EOA (iEOA) <0.85 cm 2 /m 2 , and severe PPM as an iEOA <0.65 cm 2 /m 2 . Two reviewers independently assessed the studies for inclusion and extracted data. Fourteen observational studies, involving 14 874 patients, met our final inclusion criteria. Meta-analysis demonstrated that PPM significantly increased mid-term (odds ratio [OR] 1.42, 95% confidence interval [CI] 1.19-1.69) and long-term (OR 1.52, 95% CI 1.26-1.84) all-cause mortalities. Subgroup analysis showed that PPM was associated with higher mid-and long-term mortality rates only in younger and predominantly female populations. Risk-adjusted sensitivity analysis showed that severe PPM was associated with reduced survival (adjusted hazard ratio [HR] 1.50, 95% CI 1.24-1.80), whereas moderate PPM was not (adjusted HR 0.96, 95% CI 0.86-1.07). Regardless of severity, however, PPM had a negative effect on survival in patients with impaired ejection fraction (adjusted HR 1.26, 95% CI 1.09-1.47). PPM (iEOA <0.85 cm 2 /m 2 ) after AVR tended to be associated with increased long-term all-cause mortality in younger patients, females and patients with preoperative left ventricular dysfunction. Severe PPM (iEOA <0.65 cm 2 /m 2 ) was a significant predictor of reduced long-term survival in all populations undergoing AVR.
INTRODUCTION
Prosthesis-patient mismatch (PPM), defined as a too-small effective orifice area (EOA) of an implanted prosthesis relative to patient body size, has been associated with poor prognosis after aortic valve replacement (AVR) [1] . A moderate PPM has been observed in 20-70% of patients, whereas severe PPM has been observed in 2-11% [2] . PPM, leading to residual aortic stenosis, has been associated with a higher transprosthetic gradient, bad regression of left ventricular (LV) hypertrophy and reduced survival [3, 4] .
Although mismatch after AVR is important, its effect on longterm survival remains unclear. Several recent studies have shown that PPM was independently associated with reduced late survival [5, 6] , whereas other studies have not shown an adverse impact [7, 8] . We therefore performed a meta-analysis of relevant articles to summarize the effect on late mortality of PPM, estimated by indexed EOA (iEOA) after AVR.
MATERIALS AND METHODS

Search strategy
Two observers searched for potentially relevant publications in several databases, including Medline (1966 -February 2012 , Embase (1980 -February 2012 , Cochrane controlled trials register (1990 ( -February 2012 and PubMed (update to February 2012). The search strategy used the medical subject heading (MeSH) and the keywords 'mismatch' 'aortic valve replacement' 'effective orifice area' 'survival' 'meta-analysis'.
Inclusion and exclusion criteria
Studies were included if they reported long-term survival in patients with PPM after AVR. PPM has been defined in European and American publications by the in vivo iEOA, calculated as the EOA of the prosthesis divided by the patient's body surface area [9] . Studies were included if: (a) they were original, full-text contributions in peer-reviewed journals, (b) patients had undergone AVR with a bioprosthetic or mechanical valve, (c) PPM was defined by the in vivo iEOA, (d) iEOA was considered significant if <0.85 cm 2 /m 2 and severe if <0.65 cm 2 /m 2 and (e) survival data were available with at least 5 years of follow-up. Articles were excluded if (a) PPM and non-PPM were not compared directly, (b) the follow-up time was <5 years, (c) there was no survival analysis, (d) PPM was assessed after mitral valve replacement or (e) PPM estimation was based on the in vitro EOA and geometric orifice area (GOA) rather than on the in vivo EOA.
Statistical methods
Primary analysis. Five and 10-year all-cause mortality rates were used to evaluate mid-and long-term survivals separately. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated. The significance of the OR was determined with the DerSimonian and Laird method, with P < 0.05 considered statistically significant. The calculation was weighted by study size. Heterogeneity was assessed using I 2 statistics. Funnel plots were utilized to estimate possible publication bias [10] . In subgroup analyses, the studies were divided into five categories according to age (high, mean age >65 years and low, mean age <65 years), gender (high, percentage of females >40% and low, percentage of females <40%), type of valve (mechanical, bioprosthesis or both) and preoperational LV dysfunction (ejection fraction <50%).
Secondary analysis. A baseline risk-adjusted analysis was performed to assess the confidence of our primary results by calculating aggregated adjusted hazard ratios (HRs). Several studies have shown that PPM was associated with favourable characteristics, such as higher age and lower LV ejection fraction. Forest plots were used to visually assess the HR estimates and corresponding 95% CIs, with the Mantel-Haenszel method used for subanalyses.
All data analyses were performed using STATA (version 11.0).
RESULTS
Description of the selected studies
Of the 209 initial citations, 14 fulfilled our eligibility criteria and were included in this systematic review [11, 12] (Fig. 1) . Twelve of these 14 studies were retrospective cohort analyses, whereas the other two were prospective. All studies were of high quality (score [8] [9] , as determined by the Ottawa-Newcastle criteria [13] . Tables 1 and 2 present the characteristics of the included studies and patient demographic characteristics, respectively.
Primary analysis
We conducted meta-analyses of the associations between post-AVR PPM and unadjusted 5-and 10-year all-cause mortality rates. Since the included studies showed statistical heterogeneity, we used a random-effects model. When compared with individuals without PPM, those with PPM had higher mid-(OR 1.42, 95% CI 1.19-1.69; Fig. 2 ) and long-term (OR 1.52, 95% CI 1.26-1.84; Fig. 3 ) mortality rates. Begg's funnel plots of mid-(P = 0.10) and long-term survival (P = 0.28) assessments showed no evidence of possible publication bias.
Because we observed significant heterogeneity among the included studies, we performed between-study subgroup analyses to assess the sources of heterogeneity. We found that PPM was associated with higher mid-and long-term mortality rates in younger populations and in those containing higher percentages of female patients (Table 3 ). However, the negative impact of PPM on late survival in older populations (OR 1.15, 95% CI 1.00-1.33) and in those containing lower percentages of female patients (OR 1.11, 95% CI 0.97-1.26) did not seem significant. Moreover, differences in valve type and preoperational LV function did not contribute to between-study heterogeneity. 
Secondary analysis
Of the 14 included studies, 9 contained additional data on adjusted HR. These studies used Cox proportional hazards regression models to adjust for known baseline differences between study arms. Results of all studies included in the combined risk-adjusted analysis were adjusted for age, with some studies also adjusting for gender [4, 7, 8, [14] [15] [16] , body mass index [4, 16] , ejection fraction [8, [14] [15] [16] [17] , New York Heart Association (NYHA) class [14, 16, 18, 19] , concomitant coronary artery bypass grafting (CABG) [14, 16] , prior cardiac surgery [14] , atrial fibrillation [18, 19] , chronic renal failure [15, 18] , prosthesis size [4] , prosthesis type [4, 16] (mechanical vs bioprosthestic valve), cardiopulmonary bypass time [4] , concomitant mitral surgery [14] , aortic root enlargement [14] , cerebrovascular accident [15] , vessel disease [15] , diabetes [4, [15] [16] [17] , smoking [15] and coronary artery disease [19] . Compared with patients without PPM, survival was significantly lower in patients with severe PPM (adjusted HR 1.50, 95% CI 1.24-1.80), but not in those with moderate PPM (adjusted HR 0.96, 95% CI 0.86-1.07; Fig. 4 ). Impaired ejection fraction, however, had a negative effect on patient survival, regardless of the severity of PPM (adjusted HR 1.26, 95% CI 1.09-1.47; Fig. 5 ). 
DISCUSSION
Although the haemodynamic consequences of increased transprosthetic gradients after AVR in patients with PPM have been well documented [3, 19] , the effects of PPM on long-term survival remain unclear. Studies have reported associations between aortic PPM and reduced improvement in symptoms and functional class [20] , delayed regression of LV hypertrophy and higher rates of adverse cardiac events [20, 21] . Moreover, PPM has a significant impact on long-term mortality [14, 21] . In contrast, other studies 
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have reported that PPM did not have a negative influence on LV mass index and intermediate-term survival [22] and on long-term survival [23] .
The main findings of our meta-analysis were that patients with PPM after AVR had higher unadjusted mid-and long-term mortality rates than those without PPM. Further analyses, adjusting for confounding factors, such as age, gender, valve type and LV function, showed that the adverse impact of PPM on postoperative long-term survival was more pronounced in younger than in older patients, confirming previous findings Figure 4 : Risk-adjusted analyses of the association between the risk of death and PPM (moderate and severe). [4, 5] . In general, younger patients with PPM have a more active lifestyle and a higher metabolic rate than older patients, with increased flow and an increased gradient across the valve [19] . The actual definition of PPM has not been standardized since the impact of body surface area (BSA) is non-mathematical. Various methods have been used to calculate BSA concentration without direct measurement. Mismatch may be better defined by assessing the correlation between true cardiac flow and transvalvular prosthetic gradients. This could play a role in outcome differences between younger patients with high flow generating high gradients and elderly women, with low flow but still high gradients due to small prosthetic sizes, emphasizing the importance of preventing mismatch in these patients. We also observed a significant association between reduced long-term survival and female gender, perhaps due to more severe mismatch in females than in males [15] . However, this association was probably reduced substantially by the use of smaller prosthetic valves in female patients.
Previously inconsistent results in studies analysing the effect of PPM on late survival may have been due to differences in the distribution of some risk factors. We therefore performed baseline risk-adjusted analyses, which confirmed the negative effects on survival of residual LV afterload caused by severe PPM in all patients and by PPM in patients with preoperative LV dysfunction. An increase in postoperative haemodynamic burden was less tolerated by a poorly functioning LV than by a normal LV.
In our meta-analysis, patients with PPM were identified by Doppler echocardiographic assessment of postoperative iEOA, a method that provided good sensitivity and specificity in predicting PPM [24] . The discrepancies among the previous studies may have been due to their identification of PPM by in vitro EOA [25] or GOA [26] . Several studies have shown that iGOA or iEOA derived from the manufacturers' in vitro data have little or no sensitivity in detecting PPM [24] . Therefore, studies that used in vitro EOA or GOA were not included in our meta-analysis.
Although iEOA ≤0.85 cm 2 /m 2 is now widely accepted as the threshold for aortic PPM, other thresholds have also been analysed. For example, an iEOA of ≤0.8 cm 2 /m 2 found that PPM had no impact on short-or long-term survivals [27] , although another study found that this cut-off was an independent predictor of late mortality and cardiac events [28] . Furthermore, an iEOA of ≤0.75 cm 2 /m 2 was associated with reduced survival in patients <60 years old [29] .
These results emphasize the importance of avoiding severe PPM in patients undergoing AVR. Moreover, efforts should be made to prevent PPM in all patients, particularly younger patients, females and those with impaired LV function. Surgical procedures should therefore be optimized, including the implantation of a newer generation of stented bioprostheses, bileaflet mechanical valves in a complete supra-annular position or the implantation of stentless bioprostheses. Recent multicentre studies have shown that transcatheter aortic valve implantation was associated with a lower incidence of PPM and better postoperative valve haemodynamics and LV ejection fraction than conventional surgical AVR.
This meta-analysis had several limitations. First, most of the included studies were retrospectively designed, suggesting that selection biases or unidentified confounders may have influenced their results. Secondly, we did not assess cardiac-related mortality, due to a lack of sufficient data. The relationships between causes of death and PPM were not confirmed. Thirdly, our conclusion contradicts the results of a meta-analysis of published data only. Fourthly, in order to strictly select studies with uniform definitions and reported outcomes, several studies had to be excluded. This may have eliminated some information about the impact of differently defined PPMs on survival, but our results were more accurate and credible. We believe that our results provide solid evidence of the negative impact of PPM on long-term survival, emphasizing the importance of preventing PPM in these patients.
CONCLUSIONS
This meta-analysis suggested that PPM (iEOA <0.85 cm 2 /m 2 ) after AVR tended to be associated with increased all-cause long-term mortality in younger patients, females and those with preoperative LV dysfunction. Severe PPM (iEOA <0.65 cm 2 /m 2 ) was a significant predictor of reduced long-term survival in general populations undergoing AVR. Further research is needed to 
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optimize strategies for preventing PPM, resulting in a favourable impact on patient survival after AVR.
